Prof. Dr. HAYAT YURTER

Yayın Ağı

Makaleler 26

1. Alterations in insulin-like growth factor system in spinal muscular atrophy

YEŞBEK KAYMAZ A., Bal S. K., Bora G., TALİM B., Ozon A., ALİKAŞİFOĞLU A., et al.

MUSCLE & NERVE , cilt.66, sa.5, ss.631-638, 2022 (SCI-Expanded, Scopus)

2. Rutin increases alpha-tubulin acetylation via histone deacetylase 6 inhibition

Cetin O., SARI S., Erdem-Yurter H., BORA G.

DRUG DEVELOPMENT RESEARCH , cilt.83, sa.4, ss.993-1002, 2022 (SCI-Expanded, Scopus)

3. SMN loss dysregulates microtubule-associated proteins in spinal muscular atrophy model

Ozer P. Z., Koyunoglu D., SON Ç. D., Erdem-Yurter H., BORA G.

MOLECULAR AND CELLULAR NEUROSCIENCE , cilt.120, 2022 (SCI-Expanded, Scopus)

4. MAP1B upregulation and its involvement of microtubule stability in spinal muscular atrophy

BORA G., Hensel N., Rademacher S., Koyunoglu D., Sunguroglu M., Aksu-Menges E., et al.

FEBS OPEN BIO , cilt.9, ss.32, 2019 (SCI-Expanded, Scopus)

5. Class I histone deacetylase inhibition by aryl butenoic acid derivatives: In silico and in vitro studies

BORA G., SARI S., Taskor G., DALKARA S., Erdem-Yurter H.

JOURNAL OF RESEARCH IN PHARMACY , cilt.23, sa.5, ss.952-959, 2019 (ESCI, Scopus, TRDizin)

6. Effects of Arm Cycling Exercise in Spinal Muscular Atrophy Type II Patients: A Pilot Study.

BORA G., Subasi-Yildiz Ş., Yesbek-Kaymaz A., BULUT N., Alemdaroglu I., Tunca-Yilmaz O., et al.

Journal of child neurology , cilt.33, sa.3, ss.209-215, 2018 (SCI-Expanded, Scopus)

7. Recent therapeutic developments in spinal muscular atrophy

BORA G., YEŞBEK KAYMAZ A., Bekircan Kurt C. E., HALİLOĞLU V. G., TOPALOĞLU H. A., Erdem Yurter H., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.48, sa.2, ss.203-211, 2018 (SCI-Expanded, Scopus, TRDizin)

8. Effects of Exercise on Low Density Lipoprotein Receptor Related Protein 5 Gene Expression in Patients With Postmenopausal Osteoporosis

Kilic G., DAYANGAÇ ERDEN D., Erol O., Kilic E., KARA M., Erdem Yurter H., et al.

ARCHIVES OF RHEUMATOLOGY , cilt.31, sa.4, ss.314-320, 2016 (SCI-Expanded, Scopus, TRDizin)

9. Spinal muscular atrophy type III: Molecular genetic characterization of Turkish patients

BORA-TATAR G., YESBEK-KAYMAZ A., BEKIRCAN-KURT C. E., ERDEM-OZDAMAR S., Erdem-Yurter H.

EUROPEAN JOURNAL OF MEDICAL GENETICS , cilt.58, sa.12, ss.654-658, 2015 (SCI-Expanded, Scopus)

10. Effects of flavonoid quercetin on survival of motor neuron gene expression.

Uzunalli G., Bora-Tatar G., Dayangac-Erden D., Erdem-Yurter H.

Cell biology international , cilt.39, sa.3, ss.350-4, 2015 (SCI-Expanded, Scopus)

11. Aryl butenoic acid derivatives as a new class of histone deacetylase inhibitors: synthesis, in vitro evaluation, and molecular docking studies

Esiyok P. A., Seven O., Eymur G., Tatar G. B., DAYANGAÇ ERDEN D., YELEKÇİ K., et al.

TURKISH JOURNAL OF CHEMISTRY , cilt.38, sa.2, ss.338-344, 2014 (SCI-Expanded, Scopus, TRDizin)

12. Investigations of Curcumin and Resveratrol on Neurite Outgrowth: Perspectives on Spinal Muscular Atrophy

Bora-Tatar G., Erdem-Yurter H.

BIOMED RESEARCH INTERNATIONAL , 2014 (SCI-Expanded, Scopus)

13. Spinal muscular atrophy: An oxidative stress response counteracted with curcumin

Kostel-Bal A. S., Bora-Tatar G., Erdem-Yurter H.

FREE RADICAL BIOLOGY AND MEDICINE , cilt.65, 2013 (SCI-Expanded, Scopus)

14. Carboxylic acid derivatives of histone deacetylase inhibitors induce full length SMN2 transcripts: a promising target for spinal muscular atrophy therapeutics.

Dayangac-Erden D., Bora-Tatar G., DALKARA S., DEMİR A. G., Erdem-Yurter H.

Archives of medical science : AMS , cilt.7, sa.2, ss.230-4, 2011 (SCI-Expanded, Scopus)

15. Power of inhibition activity screening and 3D molecular modeling approaches in HDAC 8 inhibitor design

Tatar G. B., Tokluman T. D., YELEKÇİ K., YURTER H.

TURKISH JOURNAL OF CHEMISTRY , cilt.35, sa.6, ss.861-870, 2011 (SCI-Expanded, Scopus, TRDizin)

16. Evaluation of the effects of vitamin D receptor and estrogen receptor 1 gene polymorphisms on bone mineral density in postmenopausal women.

Tanriover M., Tatar G., Uluturk T. D., Erden D. D., Tanriover A., Kilicarslan A., et al.

Clinical rheumatology , cilt.29, sa.11, ss.1285-93, 2010 (SCI-Expanded, Scopus)

17. The Relationship between Vitamin D Receptor Gene Polymorphisms and Bone Density, Osteocalcin Level and Growth in Adolescents

Ozaydin E., Dayangac-Erden D., Erdem-Yurter H., DERMAN O., COŞKUN T.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , cilt.23, sa.5, ss.491-496, 2010 (SCI-Expanded, Scopus)

18. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.

Bora-Tatar G., Dayangac-Erden D., DEMİR A. G., DALKARA S., Yelekci K., Erdem-Yurter H.

Bioorganic & medicinal chemistry , cilt.17, sa.14, ss.5219-28, 2009 (SCI-Expanded, Scopus)

19. Histone Deacetylase Inhibition Activity and Molecular Docking of (E )-Resveratrol: Its Therapeutic Potential in Spinal Muscular Atrophy

Dayangac-Erden D., Bora G., Ayhan P., Kocaefe C., DALKARA S., Yelekci K., et al.

CHEMICAL BIOLOGY & DRUG DESIGN , cilt.73, sa.3, ss.355-364, 2009 (SCI-Expanded, Scopus)

20. A preliminary report on spinal muscular atrophy lymphoblastoid cell lines: Are they an appropriate tool for drug screening?

Dayangac-Erden D., Topaloglu H., Erdem-Yurter H.

ADVANCES IN THERAPY , cilt.25, sa.3, ss.274-279, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. Are lymphoblastoid cell lines suitable to study increased SMN gene expression by histone deacetylase inhibitors?

DAYANGAÇ ERDEN D., Topaloglu H., YURTER H.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.38, sa.1, ss.7-12, 2008 (SCI-Expanded, Scopus, TRDizin)

22. Vitamin D receptor gene polymorphisms in Turkish children with vitamin D deficient rickets

BORA G., Oezkan B., Dayangac-Erden D., Erdem-Yurter H., COŞKUN T.

TURKISH JOURNAL OF PEDIATRICS , cilt.50, sa.1, ss.30-33, 2008 (SCI-Expanded, Scopus)

23. Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients

Dayangac-Erden D., Karaduman A., Erdem-Yurter H.

ARCHIVES OF DERMATOLOGICAL RESEARCH , cilt.299, sa.10, ss.487-491, 2007 (SCI-Expanded, Scopus)

24. COMP 297-Experimental and molecular docking simulation studies of Histone deacetylases (HDACs) enzyme inhibitors

Yelekci K., BORA G., Dayangac-Erden D., Ayhan P., DALKARA S., DEMİR A. G., et al.

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY , cilt.234, 2007 (SCI-Expanded)

25. MEDI 333-Histone deacetylase inhibition activity of resveratrol and its analogs

Dayangac-Erden D., Ayhan P., BORA G., Yelekci K., DALKARA S., DEMİR A. G., et al.

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY , cilt.234, 2007 (SCI-Expanded)

26. Analysis of the modifying effects of TAP 1/2 genes on cystic fibrosis phenotype

Ozbas-Gerceker F., Ozcelik U., Kiper N., Anadol D., Gocmen A., Yilmaz E., et al.

TURKISH JOURNAL OF PEDIATRICS , cilt.44, sa.2, ss.91-97, 2002 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 44

1. Dysregulations of microtubule plus end proteins in an in vitro spinal muscular atrophy model

ZOBAROĞLU ÖZER P., AYDIN Y., TUNÇBAĞ N., SON Ç. D., YURTER H., BORA AKOĞLU G.

48th FEBS Congress, Mining biochemistry for human health and well-being, Milan, İtalya, 29 Haziran - 03 Temmuz 2024, (Özet Bildiri)

2. Alterations of microtubule plus end tracking protein p150Glued in an in vitro Spinal muscular atrophy model

ZOBAROĞLU ÖZER P., AYDIN Y., TUNÇBAĞ N., SON Ç. D., YURTER H., BORA AKOĞLU G.

4th Scientific International congress on SMA, Ghent, Belçika, 14 - 16 Mart 2024, (Özet Bildiri)

3. Microtubule plus end tracking protein p150glued is dysregulated in spinal muscular atrophy.

ZOBAROĞLU ÖZER P., AYDIN Y., TUNÇBAĞ N., SON Ç. D., YURTER H., BORA AKOĞLU G.

TuPA 2023, Uluslararası Proteomik Kongresi, 5. Ulusal Proteomik Kongres, 13 - 14 Ekim 2023, (Özet Bildiri)

4. Is microtubule stability altered in spinal muscular atrophy patient fibroblast cells?

Zobaroğlu P., Bora G., Yurter H.

Microtubules: From Atoms to Complex Systems, EMBO/EMBL Virtual Symposium, , 3 - 06 Haziran 2020, (Yayınlanmadı)

5. Levels of Microtubule Associated Proteins in an in vitro SMA Model.

Zobaroğlu P., Bora G., Yurter H.

SMA Research and Clinical Care Meeting, 9 - 11 Haziran 2021, (Yayınlanmadı)

6. Investigation of Compounds Inducing Alpha Tubulin Acetylation by Drug Repurposing Approach.14th UK Annual Neuromuscular Translational Research Conference

Çetin Ö., Sarı S., Yurter H., Bora G.

New therapies in Neuromuscular Diseases, London, Birleşik Krallık, 25 - 26 Mart 2021, (Yayınlanmadı)

7. Investigations of Microtubule Stability in Spinal Muscular Atrophy Patient Fibroblasts.

Zobaroğlu P., Bora G., Yurter H.

Online ASCB/EMBO Meeting., 2 - 16 Aralık 2020, (Yayınlanmadı)

8. In vitro SMA Modelinde Mikrotübül Pozitif Uç Proteinlerinin Araştırılması

Bora G., Yurter H., Son Ç. D., Koyunoğlu D.

3. Nöromüsküler hastalıklar kongresi, İzmir, Türkiye, 1 - 03 Kasım 2020, (Yayınlanmadı)

9. Spinal Müsküler Atrofi Patomekanizmasında MAP1B Disregülasyonunun Rolü.

Bora G., Rademacher S., Hensel N., Yurter H.

1. Ulusal Nöromüsküler Hastalıklar Kongresi, Ankara, Türkiye, 18 - 20 Mayıs 2017, (Yayınlanmadı)

10. Contribution of altered microtubule-regulatory proteins to SMA pathomechanisms

Bora G., Koyunoğlu D., Yurter H.

Balkan Journal of Medical Genetics, 13th Balkan Human Genetics Conference, Edirne, Türkiye, 17 - 20 Nisan 2020, (Yayınlanmadı)

11. Dysregulations of microtubule plus end protein EB3 in spinal muscular atrophy.

Koyunoğlu D., Bora G., Son Ç. D., Yurter H.

2nd International Scientific Congress of Spinal Muscular Atrophy, 5 - 07 Şubat 2020, (Yayınlanmadı)

12. End-binding 3 protein alterations in an in vitro spinal muscular atrophy model

Koyunoğlı D., Bora G., Yurter H., Son Ç. D.

7th International Congress of Molecular Biology Association of Turkey, İstanbul, Türkiye, 27 - 29 Eylül 2019, (Yayınlanmadı)

13. MAP1B upregulation and its involvement of microtubule stability in spinal muscular atrophy.

Bora G., Hensel N., Rademacher S., Koyunoğlu D., Sunguroğlu M., Aksu Mengeş E., et al.

44th FEBS Congress, Krakow, Polonya, 6 - 11 Temmuz 2019, ss.2-18, (Tam Metin Bildiri)

14. MAP1B causes alterations in alpha tubulin detyrosination and microtubule stability in Spinal Muscular Atrophy

Bora G., Koyunoğlu D., Sunguroğlu M., Yurter H.

BAU International Molecular Medicine Symposium by the Bosphorus, İstanbul, Türkiye, 16 - 18 Mayıs 2019, (Yayınlanmadı)

15. Aril Bütanoik Asit Türevlerinin Sınıf I Histon Deasetilaz Enzim İnhibisyon Aktivitelerinin Araştırılması.

Bora G., Sarı S., Taşkor G., Dalkara S., Yurter H.

7. Uluslararası İlaç Kimyası Kongresi, Antalya, Türkiye, 14 - 17 Mart 2019, (Yayınlanmadı)

16. Spinal Müsküler Atrofi Patomekanizmasında MAP1B Disregülasyonunun Rolü.

Bora G., Yurter H., Hensel N., Rademacher S., Claus P.

1. Ulusal Nöromüsküler Hastalıklar Kongresi, Ankara, Türkiye, 18 - 20 Mayıs 2017, (Yayınlanmadı)

17. Low SMN Level Causes Alterations in Alpha Tubulin Detyrosination and Microtubule-associated protein 1B in Spinal Muscular Atrophy

Bora G., Rademacher S., Hensel N., Yurter H., Hayta B., Aksu Mengeş E., et al.

FEBS Advanced Lecture Course and 33rd European Cytoskeletal Forum Meeting on “Biology and pathology of cytoskeleton: the crossroads of three cytoskeletal systems., Praha, Çek Cumhuriyeti, 20 - 24 Ekim 2018, (Yayınlanmadı)

18. SMN Deficiency Causes Upregulation of Microtubule Associated Protein 1B (MAP1) in Models of Spinal Muscular Atrophy (SMA)

Bora G., Rademacher S., Hensel N., Koyunoğlu D., Claus P., Yurter H.

13th Meeting of the Mediterrranean Society of Myology and 2nd Congress of Turkish Neuromuscular Society, Nevşehir, Türkiye, 27 - 29 Haziran 2018, (Yayınlanmadı)

19. Low levels of SMN cause alterations in microtubule associated protein 1b

BORA G., Rademacher S., YEŞBEK KAYMAZ A., Hensel N., KURT C. E., ERDEM ÖZDAMAR S., et al.

21th Annual Spinal Muscular Atrophy Researcher Meeting, Orlando, Amerika Birleşik Devletleri, 29 Haziran - 02 Temmuz 2017, (Özet Bildiri)

20. Low levels of SMN cause alterations in microtubule-associated protein 1B.

Bora G., Rademacher S., Yeşbek Kaymaz A., Hensel N., Kurt C. E., Özdamar Erdem S., et al.

21th Cure SMA Researcher Meeting, Florida, Amerika Birleşik Devletleri, 29 Haziran - 03 Temmuz 2017, (Yayınlanmadı)

21. Serum IGF1 and IGFBP3 levels in SMA patients

Yeşbek Kaymaz A., Köstel Bal S., Bora G., Özön Z. A., Alikaşifoğlu A., Topaloğlu H. A., et al.

21 st World Muscle Society, Granada, İspanya, 4 - 08 Ekim 2016, (Özet Bildiri)

22. Serum IGF1 and IGFBP3 levels in SMA patients

Yeşbek Kaymaz A., Bal A. S., Bora G., Alev O., Alikasifoglu ., Topaloglu H., et al.

21st International WMS Congress, Granada, İspanya, 4 - 08 Ekim 2016, (Yayınlanmadı)

23. Serum IGF1 and IGFBP3 levels in SMA patients

Kaymaz A., Bal A., Bora-Tatar G., Ozon A., ALİKAŞİFOĞLU A., TOPALOĞLU H. A., et al.

21st International Congress of the World-Muscle-Society, Granada, Nikaragua, 4 - 08 Ekim 2016, cilt.26, (Özet Bildiri)

24. Microtubule-associated protein 1B is dysregulated in Spinal Muscular Atrophy.

Bora G., Rademacher S., Hensel N., Claus P., Yurter H.

41th FEBS Conference, Aydın, Türkiye, 3 - 08 Eylül 2016, (Yayınlanmadı)

25. Microtubule-associated protein 1B is dysregulated in spinal muscular atrophy

Bora-Tatar G., Rademacher S., Hensel N., Claus P., Erdem-Yurter H.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.28-29, (Özet Bildiri)

26. Effects of exercise training in spinal muscular atrophy type II patients

BORA TATAR G., SUBAŞI Ş., YEŞBEK KAYMAZ A., Tunca Yılmaz Ö., TOPALOĞLU H. A., KARADUMAN A. A., et al.

19th Annual Spinal Muscular Atrophy Researcher Meeting, Kansas, Amerika Birleşik Devletleri, 18 Haziran 2015 - 20 Haziran 2016, (Özet Bildiri)

27. IGF System Elements in SMA Patients

YEŞBEK KAYMAZ A., Köstel Bal S., BORA G., ÖZÖN Z. A., ALİKAŞİFOĞLU A., TOPALOĞLU H. A., et al.

20th Annual Spinal Muscular Atrophy Researcher Meeting, Anaheim, Amerika Birleşik Devletleri, 16 - 19 Haziran 2016, (Özet Bildiri)

28. Skeletal muscle expression of insulin like growth factor system elements in spinal muscular atrophy patients

YEŞBEK KAYMAZ A., TALİM B., BORA G., YURTER H.

5th International Congress of Myology, Lyon, Fransa, 14 - 18 Mart 2016, (Özet Bildiri)

29. Spinal müsküler atrofi hastalarının iskelet kasında insülin benzeri büyüme faktörleri ve bağlayıcı protein düzeylerinin araştırılması

Yeşbek Kaymaz A., Bora G., Yurter H., Talim B.

XIV. Ulusal Tibbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 27 - 30 Ekim 2015, (Yayınlanmadı)

30. Effects of exercise training in spinal muscular atrophy type 2 patients

Bora Tatar G., Subaşı Ş., Yeşbek Kaymaz A., Yılmaz Ö., Topaloğlu H. A., Karaduman A. A., et al.

19th Annual Spinal Muscular Atrophy Researcher Meeting, Kansas, Amerika Birleşik Devletleri, 18 - 20 Haziran 2015, (Yayınlanmadı)

31. Spinal müsküler atrofi hastalarının iskeletkasında insulin benzeri büyüme faktörleri ve bağlayıcı protein düzeylerinin araştırılması

YEŞBEK KAYMAZ A., TALİM B., BORA TATAR G., YURTER H.

XIV. Ulusal Tıbbi Biyoloji ve Genetik kongresi, Fethiye, Türkiye, 27 Ekim 2015 - 30 Ekim 2014, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

293

H-İndeks (WoS)

Atıf (Scopus)

378

H-İndeks (Scopus)

Proje

Fikri Mülkiyet

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Fikri Mülkiyet

Tez Danışmanlığı

Açık Erişim